Skip to main content
OpenTrials

Clinical trial condition

Epilepsies, Partial

Explore clinical trials studying Epilepsies, Partial. Study availability and eligibility vary by location and protocol.

185 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Epilepsies, Partial trial results

Completed

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

NCT00988429

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • University of South Alabama Department of Neurology Mobile, Alabama, United States
  • Neurology Clinic, P.C. Northport, Alabama, United States
  • 21st Century Neurology - Division of Xenoscience, Inc. Phoenix, Arizona, United States
  • Barrow Neurological Institute / St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 162 locations
View Trial Details
Completed

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Neurology Center, P.C. Mobile, Alabama, United States
  • Premier Medical Group Mobile, Alabama, United States
  • Neurology Clinic, PC Northport, Alabama, United States
  • North River Ophthalmology Tuscaloosa, Alabama, United States
View all 150 locations
View Trial Details
Completed

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

NCT00437281

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Jonesboro, Arkansas, United States
View all 18 locations
View Trial Details
Completed

A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00620555

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
  • Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
  • Pfizer Investigational Site Kobe, Hyōgo, Japan
  • Pfizer Investigational Site Suma-Ku,Kobe, Hyōgo, Japan
View all 22 locations
View Trial Details
Completed

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00603473

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Obu-shi,Morioka-machi, Aichi-ken, Japan
  • Pfizer Investigational Site Jonan-ku, Fukuoka, Japan
  • Pfizer Investigational Site Sapporo, Hokkaido, Japan
  • Pfizer Investigational Site Kobe, Hyōgo, Japan
View all 26 locations
View Trial Details
Completed

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • Pfizer Investigational Site Bruges, Belgium
  • Pfizer Investigational Site Brussels, Belgium
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Plovdiv, Bulgaria
View all 102 locations
View Trial Details
Completed

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

NCT00596466

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +2 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Fayetteville, Arkansas, United States
  • Pfizer Investigational Site Fullerton, California, United States
  • Pfizer Investigational Site Long Beach, California, United States
View all 44 locations
View Trial Details

Related conditions